Pfizer, Sandoz Patent Spat Over Caduet Heads To Del.
Pfizer Inc. has won its bid to transfer to Delaware federal court a patent infringement case over Sandoz Inc.'s abbreviated new drug application to manufacture a generic version of blood pressure...To view the full article, register now.
Already a subscriber? Click here to view full article